Industrials [ 7/12 ] | Trading Companies & Distributors [ 58/73 ]
NASDAQ | Common Stock
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms.
The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment.
It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers.
The company was founded in 2008 and is headquartered in Irving, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 5, 25 | 0.08 Decreased by -96.08% | -0.16 Increased by +150.00% |
| Aug 12, 25 | -1.11 Decreased by -160.00% | -0.22 Decreased by -404.55% |
| May 28, 25 | -0.35 Decreased by -119.89% | - |
| Nov 5, 21 | 2.82 Increased by +171.15% | 1.94 Increased by +45.36% |
| Aug 3, 21 | 2.04 Increased by +151.63% | 1.78 Increased by +14.61% |
| Apr 29, 21 | 1.85 Increased by +176.12% | 1.66 Increased by +11.45% |
| Feb 16, 21 | 1.76 Increased by +225.93% | 1.13 Increased by +55.30% |
| Oct 29, 20 | 1.04 Increased by +40.54% | 0.88 Increased by +18.18% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 216.83 M Increased by +168.77% | 24.32 M Increased by +121.91% | Increased by +11.22% Increased by +108.15% |
| Jun 30, 25 | 181.40 M Increased by +79.91% | -71.79 M Decreased by -240.34% | Decreased by -39.58% Decreased by -178.00% |
| Mar 31, 25 | 120.92 M Increased by +41.10% | -102.58 M Decreased by -370.36% | Decreased by -84.84% Decreased by -291.61% |
| Jun 30, 24 | 100.05 M Increased by +23.82% | -66.19 M Decreased by -285.19% | Decreased by -66.15% Decreased by -249.56% |
| Mar 31, 24 | 80.68 M Increased by +25.43% | -111.03 M Decreased by -879.36% | Decreased by -137.62% Decreased by -721.35% |
| Sep 30, 21 | 100.83 M Increased by +27.55% | 51.16 M Increased by +231.25% | Increased by +50.74% Increased by +159.71% |
| Jun 30, 21 | 85.69 M Increased by +13.17% | 37.94 M Increased by +6.16 K% | Increased by +44.28% Increased by +5.46 K% |
| Mar 31, 21 | 80.80 M Decreased by -23.06% | 35.74 M Increased by +2.79 K% | Increased by +44.23% Increased by +3.59 K% |